The consequences of multiple simultaneous C-type lectin-ligand interactions: DCIR alters the endo-lysosomal routing of DC-SIGN

Frontiers in Immunology

Volumn 6, Issue MAR, 2015, Pages

  García Vallejo, Juan J ^a   Bloem, Karien ^a,b,d   Knippels, Léon M J ^b,c   Garssen, Johan ^b,c   van Vliet, Sandra J ^a   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d SANQUIN RESEARCH   (Netherlands)

Author keywords

Antigen uptake; Dendritic cell immunoreceptor; Dendritic cell specific intercellular adhesion molecule 3 grabbing non integrin; Dendritic cells; Intracellular routing; Macrophage galactose type lectin; Mannose receptor

Indexed keywords

BIOLOGICAL FACTOR; CD209 ANTIGEN; DENDRITIC CELL IMMUNORECEPTOR; EARLY ENDOSOME ANTIGEN 1; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; STREPTAVIDIN; TETRAMETHYLBENZIDINE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL STIMULATION; CORRELATION COEFFICIENT; DENDRITIC CELL; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; OPTICAL DENSITY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECYCLING;

EID: 84926655625     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00087     Document Type: Article

References (51)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (1998) 392:245-52. doi: 10.1038/32588
2. Tacken PJ, Ginter W, Berod L, Cruz LJ, Joosten B, Sparwasser T, et al. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. Blood (2011) 118:4111-9. doi:10.1182/blood-2011-04-346957
3. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol (2005) 23:975-1028. doi:10.1146/annurev.immunol.22.012703.104538
4. Garcia-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem K, Unger WW, et al. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol (2013) 53:387-97. doi:10.1016/j.molimm.2012.09.012
5. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 12:557-69. doi:10.1038/nri3254
6. Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, et al. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release (2012) 160:88-95. doi:10.1016/j.jconrel.2012.02.007
7. van Vliet SJ, Aarnoudse CA, Broks-van den Berg VC, Boks M, Geijtenbeek TB, van Kooyk Y. MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5. Eur J Immunol (2007) 37:2075-81. doi:10.1002/eji.200636838
8. Matzinger P. The danger model: a renewed sense of self. Science (2002) 296:301-5. doi:10.1126/science.1071059
9. Napoletano C, Rughetti A, Agervig Tarp MP, Coleman J, Bennett EP, Picco G, et al. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res (2007) 67:8358-67. doi:10.1158/0008-5472.CAN-07-1035
10. Förster R, Braun A, Worbs T. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol (2012) 33:271-80. doi:10.1016/j.it.2012.02.007
11. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, de Vries IJ, et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood (2008) 111:4245-53. doi:10.1182/blood-2007-03-081398
12. Klechevsky E, Flamar A-L, Cao Y, Blanck J-P, Liu M, O'Bar A, et al. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood (2010) 116:1685-97. doi:10.1182/blood-2010-01-264960
13. van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol (2008) 9:593-601. doi:10.1038/ni.f.203
14. Meyer-Wentrup F, Cambi A, Joosten B, Looman MW, de Vries IJ, Figdor CG, et al. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol (2009) 85:518-25. doi:10.1189/jlb.0608352
15. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol (2009) 9:465-79. doi:10.1038/nri2569
16. Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ, et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 163:1973-83.
17. Sancho D, Reis E, Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol (2012) 30:491-529. doi:10.1146/annurev-immunol-031210-101352
18. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y. Self-and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol (2004) 22:33-54. doi:10.1146/annurev.immunol.22.012703.104558
19. Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, et al. DCIR interacts with ligands from both endogenous and pathogenic origin. Immunol Lett (2014) 158:33-41. doi:10.1016/j.imlet.2013.11.007
20. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 100:587-97. doi:10.1016/S0092-8674(00)80694-7
21. Turville SG, Arthos J, Donald KM, Lynch G, Naif H, Clark G, et al. HIV gp120 receptors on human dendritic cells. Blood (2001) 98:2482-8. doi:10.1182/blood.V98.8.2482
22. Flinsenberg TW, Compeer EB, Boelens JJ, Boes M. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin Exp Immunol (2011) 165:8-18. doi:10.1111/j.1365-2249.2011.04411.x
23. van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk BJ, Irimura T, et al. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int Immunol (2005) 17:661-9. doi:10.1093/intimm/dxh246
24. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell (2000) 100:575-85. doi:10.1016/S0092-8674(00)80693-5
25. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Eilering JB, Martin MP, et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med (2001) 193:671-8. doi:10.1084/jem.193.6.671
26. Lanzavecchia A, Abrignani S, Scheidegger D, Obrist R, Dörken B, Moldenhauer G. Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J Exp Med (1988) 167:345-52. doi:10.1084/jem.167.2.345
27. Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol (1997) 27:2426-35. doi:10.1002/eji.1830270942
28. Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol (1997) 27:2417-25. doi:10.1002/eji.1830270941
29. Garcia-Vallejo JJ, Ilarregui JM, Kalay H, Chamorro S, Koning N, Unger WW, et al. CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG. J Exp Med (2014) 211:1465-83. doi:10.1084/jem.20122192
30. Singh SK, Streng-Ouwehand I, Litjens M, Kalay H, Burgdorf S, Saeland E, et al. Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization. Eur J Immunol (2011) 41:916-25. doi:10.1002/eji.201040762
31. Stahl P, Schlesinger PH, Sigardson E, Rodman JS, Lee YC. Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell (1980) 19:207-15. doi:10.1016/0092-8674(80)90402-X
32. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med (1995) 182:389-400. doi:10.1084/jem.182.2.389
33. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol (2002) 168:2118-26. doi:10.4049/jimmunol.168.5.2118
34. Tacken PJ, de Vries IJ, Gijzen K, Joosten B, Wu D, Rother RP, et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood (2005) 106:1278-85. doi:10.1182/blood-2005-01-0318
35. Azad AK, Torrelles JB, Schlesinger LS. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. J Leukoc Biol (2008) 84:1594-603. doi:10.1189/jlb.0308192
36. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity (2002) 16:135-44. doi:10.1016/S1074-7613(02)00259-5
37. Tacken PJ, Huurne Ter M, Torensma R, Figdor CG. Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking. Eur J Immunol (2012) 42:1989-98. doi:10.1002/eji.201142258
38. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol (2012) 30:1-22. doi:10.1146/annurev-immunol-100311-102839
39. Higashi N, Fujioka K, Denda-Nagai K, Hashimoto S-I, Nagai S, Sato T, et al. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J Biol Chem (2002) 277:20686-93. doi:10.1074/jbc.M202104200
40. Kruskal BA, Sastry K, Warner AB, Mathieu CE, Ezekowitz RA. Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor. J Exp Med (1992) 176:1673-80. doi:10.1084/jem.176.6.1673
41. Schweizer A, Stahl PD, Rohrer J. A di-aromatic motif in the cytosolic tail of the mannose receptor mediates endosomal sorting. J Biol Chem (2000) 275:29694-700. doi:10.1074/jbc.M000571200
42. O'Reilly MK, Tian H, Paulson JC. CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J Immunol (2011) 186:1554-63. doi:10.4049/jimmunol.1003005
43. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol (2000) 151:673-84. doi:10.1083/jcb.151.3.673
44. Napoletano C, Zizzari IG, Rughetti A, Rahimi H, Irimura T, Clausen H, et al. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Eur J Immunol (2012) 42:936-45. doi:10.1002/eji.201142086
45. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RA, et al. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A (2010) 107:4287-92. doi:10.1073/pnas.0910609107
46. Bloem K, Vuist IM, van der Plas A-J, Knippels LM, Garssen J, Garcia-Vallejo JJ, et al. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain. PLoS One (2013) 8:e66266. doi:10.1371/journal.pone.0066266
47. Lambert AA, Barabé F, Gilbert C, Tremblay MJ. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood (2011) 117:6589-99. doi:10.1182/blood-2011-01-331363
48. van Vliet SJ, Bay S, Vuist IM, Kalay H, Garcia-Vallejo JJ, Leclerc C, et al. MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukoc Biol (2013) 94:315-23. doi:10.1189/jlb.1012520
49. Geijtenbeek TB, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk BJ, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med (2003) 197:7-17. doi:10.1084/jem.20021229
50. Li D, Romain G, Flamar A-L, Duluc D, Dullaers M, Li X-H, et al. Targeting self-and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med (2012) 209:109-21. doi:10.1084/jem.20110399
51. Dam TK, Brewer CF. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology (2009) 20(3):270-9. doi:10.1093/glycob/cwp186